Current Market Information

Last Trade Price (LTP) 9.70 Last Trade Date 28 January, 2025 Change -2.02 % Open Price 9.90 Day's Range 9.70 - 9.70     Total Trade 3 Total Volume 1500 Close Price 9.70 Yesterday Close Price 9.90 Market Capital in BDT (mn) 1127.190

Contact Information

Designation Name Mobile Number Email Chairman Mrs. Hafiza Yeasmin 01731936799 hafizaibpl@gmail.com MD A. F. M. Anowarul Huq 01711345816 sabila707@gmail.com CFO Md. Faruque Hossain 01883011125 cfoibpl@gmail.com Company Secretary Mohi Uddin 01777685176 mahfuzdk85@yahoo.com Office Address Plot-183 (7th Floor), Block-B, Ahmed Akber Sobhan Road, Bashundhara R/A, Dhaka-1229. Phone : 09678777995 Fax : Email : info@indo-banglapharma.com Website : http://www.indo-banglapharma.com Factory Address 729, BM College Road, Barishal Sadar, Barishal-8200

Basic Information

Authorized Capital in BDT* (mn) 1,500.00 Paid-up Capital in BDT* (mn) 1,162.05 Face Value 10 Paid up Share 116205178     Market Lot 1 Sector PHARMA & CHEMICALS Market Category Z

Other Information

Listing Year 2018 Debut Trade Date 18 October, 2018 Type of Instrument     52 Week's Range 7.20 - 20.20 Year End 30 June Reserve / Surplus(mn) 418.79 Remarks Note

Share Holding Percentage

Sponsor/Director Govt. Institute Foreign Public As on 31-Dec, 2024 27.89 0 15.7 0 56.41 As on 30-Nov, 2024 27.94 0 15.61 0 56.45 As on 31-Oct, 2024 27.94 0 15.66 0 56.4 As on 30-Jun, 2024 (year ended) 27.94 0 15.89 0 56.17     Remarks Note     Credit Rating Status Credit Rating Year Long Term Short Term Outlook Validity Date Credit Rating Company Nov 06, 2024 BBB ST-3 Stable Nov 25, 2025 Emerging Credit Rating Ltd Nov 06, 2023 BBB ST-3 Stable Nov 05, 2024 Emerging Credit Rating Ltd Nov 06, 2022 BBB ST-3 Stable Nov 05, 2023 Emerging Credit Rating Ltd         Half Year End (HY) Information  202312 HY Net Turnover(mn)  143.35 HY Net Profit after tax(mn)  -5.57 HY EPS  -0.05  AGM Information   AGM Date  26 December, 2024 Record Date  03 December, 2024 Dividend(%)  0.10 (June 2024) Bonus Issue  3% 2021,2% 2020,9% 2019, 10% 2018

   

Financial Performance
Performance Year	Basic EPS Based On		Basic EPS (restated) Based On		Net Asset Value Per Share	Restated Net Asset Value Per Share	Net Profit After Tax(mn)		% Dividend	% Dividend Yield
	Continuous operations	Including Extra-Ordinary Income	Continuous operations	Including Extra-Ordinary Income			Continuous operations	Including Extra-Ordinary Income
2024	-0.35	0	0	0	13.6	0	-40.98	0	0.1C%	0.08
2023	0.07	0	0	0	13.96	0	8.41	0		0
2022	0.22	0	0	0	13.98	0	25.17	0	1%C	0.56
2021	1.18	0	0	0	14.29	0	134.73	0	4%C,3%B	2.02
2020	1.4	0	0	0	13.61	0	156.24	0	4.5%C,2%B	2.18

Financial Statements
Quarterly Financial Statement	https://www.indo-banglapharma.com/site/investor?cat=Quarterly Report
Price Sensitive Information	https://www.indo-banglapharma.com/site/investor?cat=PSI

Close Price and Traded Volume Graph
Click here to view 1 month graph	Click here to view 3 month graph	Click here to view 6 month graph
Form	To